CAM JAPAN HDG(03160),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03160 CAM JAPAN HDG

Not Yet Opened 01-08 16:08:09

27.220

-0.240

-0.87%

High27.460	Low27.100	Vol11.46K
Open27.460	D1 Closing27.460	Amplitude1.31%
Mkt Cap1.75B	Tradable Cap585.23M	Total Shares64.20M
T/O312.69K	T/O Rate0.05%	Tradable Shares21.50M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03160","market":"HK","secType":"STK","nameCN":"CAM JAPAN HDG","latestPrice":27.22,"timestamp":1767859689005,"preClose":27.46,"halted":0,"volume":11457,"delay":0,"floatShares":21500000,"shares":64200000,"eps":0,"marketStatus":"Not Yet Opened","change":-0.24,"latestTime":"01-08 16:08:09","open":27.46,"high":27.46,"low":27.1,"amount":312692,"amplitude":0.01311,"askPrice":28,"askSize":1000,"bidPrice":27.22,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1767922200000},"marketStatusCode":0,"adr":0,"listingDate":1455724800000,"exchange":"SEHK","adjPreClose":27.46,"sharesOutstanding":21400000,"nav":27.6523,"aum":690018436.003,"dividendRate":0.012123,"bidAskSpread":0,"openAndCloseTimeList":[[1767835800000,1767844800000],[1767848400000,1767859200000]],"volumeRatio":0.078931,"lotSize":200,"spreadScale":3,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03160/wiki","defaultTab":"wiki","newsList":[{"id":"2601668360","title":"Press Release: VolitionRx Secures $2.0 Million in Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2601668360","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601668360?lang=en_us&edition=fundamental","pubTime":"2026-01-08 22:15","pubTimestamp":1767881700,"startTime":"0","endTime":"0","summary":"HENDERSON, Nev., Jan. 8, 2026 /PRNewswire/ -- VolitionRx Limited  , a multi-national epigenetics company, announced today that it has entered into an amended and restated securities purchase agreement  with Lind Global Asset Management XII LLC , an investment fund managed by The Lind Partners, a New York-based institutional fund manager. Under the Amended Agreement, the Company will receive aggregate gross proceeds of $2,000,000 from the Investor in exchange for the issuance to the Investor of a senior secured convertible promissory note in the principal amount of $2,400,000 , and a five-year common stock purchase warrant to purchase up to 7,000,350 shares of the Company's common stock at an exercise price of $0.5714 per share , subject to the satisfaction of certain closing conditions. As additional consideration to Investor, we have agreed to pay a commitment fee in the amount of $70,000, which shall be paid by deduction from the funding to be received.This press release shall not co","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4588","TM","BK4198","VNRX","BK4099","BK4232","03160","BK4022","BK4604","BK4555","BK4585"],"gpt_icon":0},{"id":"2601364197","title":"Press Release: MannKind Provides Business Updates and 2026 Growth Drivers","url":"https://stock-news.laohu8.com/highlight/detail?id=2601364197","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601364197?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:05","pubTimestamp":1767877500,"startTime":"0","endTime":"0","summary":"DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Jan. 08, 2026  -- MannKind Corporation , a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions for cardiometabolic and orphan lung diseases, today provided business updates and outlined anticipated growth drivers for 2026, including progress across its commercial programs and clinical development initiatives.\"MannKind closed 2025 on a high note, marked by milestones that reinforce our growth trajectory--including the acquisition of scPharmaceuticals and a record-setting fourth quarter surpassing $100 million in net revenue,\" said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. \"With two high-potential launches on the horizon, 2026 is shaping up to be a catalyst-rich year that positions MannKind for long-term value creation.\". -- FDA decision on Afrezza label update  anticipated with a. -- Would update the initial dose for mealtime insulin when switc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4232","BK4604","BK4139","BK4022","TM","BK4584","BK4588","BK4585","R","BK4099","BK4555","MNKD"],"gpt_icon":0},{"id":"2601103364","title":"Press Release: CorMedix Therapeutics Announces Leadership and Board Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2601103364","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601103364?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:05","pubTimestamp":1767877500,"startTime":"0","endTime":"0","summary":"BERKELEY HEIGHTS, N.J., Jan. 08, 2026  -- CorMedix Therapeutics , a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced an addition to its executive leadership team and updates to its Board of Directors. CorMedix CEO Joseph Todisco has signed an extended employment contract, reaffirming his long-term commitment to the organization. In addition to his role as CEO, Mr. Todisco will also assume the role of Chairman of the Board of Directors, succeeding Myron Kaplan. Mr. Kaplan will transition into a newly created board position of Lead Independent Director.CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. CorMedix is commercializing DefenCath  for the prevention of catheter-related bloodstream infections in adult patients undergoing hemodialysis via ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","BK4555","CRMD","BK4007","LENZ","BK4099","BK4604","R","BK4585","TM","BK4588","BK4022","03160","BK4232"],"gpt_icon":0},{"id":"2601643443","title":"Press Release: Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2601643443","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601643443?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:00","pubTimestamp":1767877200,"startTime":"0","endTime":"0","summary":"PHILADELPHIA, Jan. 08, 2026  -- Century Therapeutics, Inc. , a biotechnology company developing induced pluripotent stem cell -derived cell therapies for autoimmune diseases and cancer, today announced it has entered into a securities purchase agreement for a private placement for initial gross proceeds of approximately $135 million to the Company, before placement agent fees and offering expenses.The financing is being led by new investor TCGX, and includes participation from additional new and existing investors, including RA Capital Management, Commodore Capital, Deep Track Capital, RTW Investments, Venrock Healthcare Capital Partners, and the T1D Fund. The private placement is expected to close on January 9, 2026, subject to customary closing conditions.Century intends to use the net proceeds from the private placement to fun","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4150","03160","BK4585","CNTY","BK4505","BK4604","BK4588","BK4539","IPSC","TM","BK4099","BK4139","BK4555"],"gpt_icon":0},{"id":"2601046366","title":"Customs Scraps Paper; Tankers Seized; CSX Layoffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2601046366","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601046366?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:04","pubTimestamp":1767873840,"startTime":"0","endTime":"0","summary":"Customs Scraps Paper Refund Checks; U.S. Seizes Two Tankers; CSX Lays Off 166 Managers By Mark R. Long | WSJ Logistics Report. The U.S. government is speeding up its tariff-refund process as importers await a landmark Supreme Court decision on the Trump administration's levies.that would make it quicker and easier to claim back payments, part of a plan across the federal government to eliminate paper payments. The Treasury Department will stop issuing paper checks for refunds as of Feb. 6, except in select cases.U.S. importers, customs brokers and trade lawyers are waiting for the Supreme Court. Early Wednesday, a special-operations force boarded the Marinera, a tanker formerly known as the Bella 1. The Coast Guard had pursued the vessel for two weeks on an odyssey that began near Venezuela and ended south of Iceland, U.S. officials said. The vessel-which wasn't carrying any oil-changed its name and claimed Russian protection , and a Russian navy ship and submarine began escorting it. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4566","LU0314106906.USD","TM","CSX","IE00B3S45H60.SGD","IE00BSNM7G36.USD","IE00B29SXL02.USD","IE00BFXG1179.USD","BK4604","IE00BD4GTT62.SGD","BK4585","03160","BK4016","LU2346227817.USD","BK4532","IE00BD4GTV84.USD","LU1074936037.SGD","IE00B29SXK94.USD","LU1506573853.SGD","IE00B775SV38.USD","BK4520","BK4555","BK4099","IE00BD4GTW91.USD"],"gpt_icon":0},{"id":"1150496893","title":"Holding Billions but \"Not Going Public\": Moon's Dark Side Stays in the \"Shadows\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1150496893","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150496893?lang=en_us&edition=fundamental","pubTime":"2026-01-08 19:58","pubTimestamp":1767873496,"startTime":"0","endTime":"0","summary":"At the end of 2025, a company-wide letter from Yang Zhilin, founder and CEO of Moon's Dark Side (Kimi), seemed to provide a perfect year-end summary for the company. He stated, \"The amounts raised in...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002828.SGD","LU2360106780.USD","LU0651947912.USD","LU0106252389.USD","LU1064131003.USD","LU0593848301.USD","SG9999004220.SGD","LU0203347892.USD","LU0541502299.USD","BK1233","LU2476274720.SGD","LU2125910849.SGD","LU2449936058.SGD","LU2237443978.SGD","LU0651946864.USD","SGXZ81514606.USD","TCHmain","LU0072913022.USD","LU0329678337.USD","LU0455707207.USD","LU0345775950.USD","LU0672654240.SGD","IE0009570106.USD","LU1429558221.USD","LU0047713382.USD","SG9999013353.USD","LU0823414478.USD","BK1618","LU2360107168.USD","LU0049853897.USD","LU0456842615.SGD","LU1548497426.USD","LU1794554557.SGD","LU0708995583.HKD","LU1880383366.USD","LU1066051498.USD","LU2097828714.EUR","LU2242644610.SGD","LU1224709979.USD","LU0572939691.SGD","SG9999015945.SGD","BK1583","LU1974910355.USD","LU0823426480.USD","LU0348784397.USD","LU0316494557.USD","LU0456846285.SGD","LU1051769294.HKD","IE0003795394.USD","LU1861215975.USD","LU0084288322.USD","SG9999017495.SGD","LU1282651048.USD","SG9999002562.SGD","LU0890818403.SGD","LU0918141887.USD","LU0359201885.HKD","LU0067412154.USD","LU1048588211.SGD","HK0000306685.HKD","BK4588","LU1226288253.USD","LU0611395673.USD","LU0293314216.USD","LU1145028129.USD","LU0049112450.USD","LU0819123356.HKD","LU1224444064.USD","LU1769817096.USD","LU0608807946.USD","LU2177674079.SGD","LU0577902611.USD","LU0708995401.HKD","IE0008368742.USD","LU1861558580.USD","SG9999001226.SGD","TSYW.SI","LU0048388663.USD","SGXZ99366536.SGD","LU1439102457.SGD","LU0456827905.SGD","LU0689472784.USD","LU2237443549.SGD","LU2249611893.SGD","BK1586","LU2257852520.SGD","LU0862451837.USD","LU1435385759.SGD","LU0823039010.USD","SG9999015986.USD","IE00B8HQ1Z84.USD","LU0594300419.USD","BK4555","LU1808992512.USD","LU1211504680.USD","LU0797268264.HKD","IE00BK4W5L77.USD","SG9999000418.SGD","LU1044874839.SGD","IE00BZ08YS42.EUR","LU0499858438.USD","LU1981816686.USD","LU0561508036.HKD","LU0642271901.SGD","BK4550","LU1481107354.HKD","LU0819121731.USD","LU0469268626.HKD","SG9999014906.USD","LU1839511570.USD","LU2476274308.USD","LU0823397103.USD","LU0823413660.USD","LU0048597586.USD","BK1608","HK0000306701.USD","BK4534","LU0831103253.SGD","LU1720051108.HKD","IE00B5MMRT66.SGD","IE0034224299.USD","LU1046422090.SGD","LU0228367735.SGD","LU1226288097.SGD","LU1642822792.SGD","IE0031814852.USD","IE0008369823.USD","LU0117844026.USD","LU0650527681.SGD","LU0588546209.SGD","03160","LU0882747503.HKD","LU0329678170.USD","LU0737861772.HKD","LU1023057109.AUD","LU2250418816.HKD","LU1267930730.SGD","LU1733274390.USD","SG9999018857.SGD","LU2087621335.USD","LU0633140560.USD","LU0738912210.USD","LU0143863198.USD","LU0210536198.USD","LU0320764243.SGD","LU1044875133.USD","LU1551013425.SGD","LU0886674414.USD","LU0784639295.USD","LU0823040885.USD","LU1366334578.USD","BK6511","LU0149721374.USD","LU0516423174.USD","LU0196878994.USD","LU1102505762.USD","LU0254981946.USD","LU0188438112.USD","LU2403377893.USD","BK1502","LU0466842654.USD","LU2279701549.SGD","LU1251922891.USD","LU1770034418.SGD","BK4592","BK1526","LU0431992006.USD","LU0164865239.USD","LU0173614495.USD","BK1095","LU0348805143.USD","5RE.SI","LU0499858602.USD","IE00BPRC5H50.USD","IE00BK4W5M84.HKD","IE00B1BXHZ80.USD","LU0106259558.USD","IE00BWXC8680.SGD","LU0326950275.SGD","LU0327786744.USD","LU2213496289.HKD","LU2896262040.SGD","LU0820561818.USD","LU2023250330.USD","SGXZ31699556.SGD","LU1282648689.USD","LU0348825331.USD","LU2756315318.SGD","LU1282649067.USD","IE00B0169N27.USD","LU0588545730.USD","LU0605514214.HKD","LU1226287875.USD","SG9999007991.SGD","LU1152091754.HKD","LU0140636845.USD","LU0589944569.HKD","LU1366192091.USD","LU0588545490.SGD","IE0032834883.USD","LU2023250504.SGD","IE00BZ08YR35.GBP","LU0043850808.USD","LU0029874905.USD","LU1769817179.HKD","LU2097828631.EUR","LU3063872942.SGD","LU0823038988.USD","LU0786609619.USD","LU1725190679.HKD","LU2456880835.USD","LU1282649141.HKD","LU1066051225.USD","LU1814569148.SGD","IE00BJLML261.HKD","LU0820562030.AUD","SG9999014674.SGD","LU1105468828.SGD","LU1883866441.USD","LU0985320562.USD","LU0540923850.HKD","LU2237443465.HKD","IE00BF5LJ272.USD","IE0003895053.USD","LU0441854154.USD","LU0323591593.USD","LU2063271972.USD","LU0345769128.USD","LU1232071149.USD","LU0880133367.SGD","LU0127658192.USD","LU2045819591.USD","LU0588545904.SGD","LU2125910500.SGD","LU0307460666.USD","LU1328277881.USD","SG9999001846.SGD","LU0737861699.HKD","LU0054237671.USD","LU0348814723.USD","LU1961090484.USD","IE00BZ08YT58.USD","LU0873338254.USD","LU0203345920.USD","LU0516422440.USD","LU0543330483.HKD","LU0228659784.USD","BK4612","LU1515016050.SGD","LU0823411888.USD","IE00B3M56506.USD","LU0051755006.USD","METmain","LU0577902454.USD","LU0234570918.USD","BK4551","LU0964807845.USD","LU0648948544.HKD","LU2357305700.SGD","LU0791591158.USD","LU2778985437.USD","LU0417516902.SGD","BK1591","LU0572944931.SGD","LU0048580855.USD","BK1609","02513","SG9999014914.USD","BK1142","LU1316542783.SGD","LU0572940350.SGD","LU2317271919.USD","LU2362541513.USD","BK4604","LU2097828474.EUR","LU1956131251.USD","LU2462611646.USD","LU1861220033.SGD","LU0821914370.USD","LU0791590937.USD","LU0359201612.USD","IE00BSNM7G36.USD","LU0633140727.USD","LU1568876251.USD","LU1813983027.USD","SG9999002463.SGD","BK1615","LU0261950983.USD","SG9999018865.SGD","LU0164880469.USD","SG9999003461.SGD","BK4543","IE00B543WZ88.USD","LU0096374516.USD","IE00B29SXG58.USD","LU0502904849.HKD","IE00B8L5B284.USD","LU1328615791.USD","BK4516","LU0414403682.SGD","LU1102505929.USD","LU1282651121.HKD","LU2471134523.USD","LU0348816934.USD","LU0675040207.SGD","LU0229945570.USD","LU0719512351.SGD","IE00B0169L03.USD","LU1064130708.USD","LU1439103000.SGD","LU2237443622.USD","IE00B97KM107.HKD","LU0132412106.USD","BK4132","IE00BQXX3D17.EUR","LU0039217434.USD","LU0823397285.USD","GB00BDT5M118.USD","LU1196710864.SGD","LU0244354667.USD","SGXZ90724238.SGD","LU0072462343.USD","LU1226288170.HKD","LU1629891620.HKD","LU1733274473.HKD","LU0577902371.SGD","IE0032431581.USD","BK4099","LU0164872284.USD","LU0264606111.USD","IE0001KFT4U8.USD","LU2251237488.HKD","IE00BGV7N243.SGD","IE00BQXX3F31.USD","LU0011963245.USD","LU0211331839.USD","IE00B19Z8X17.USD","LU1868837722.USD","LU0077335932.USD","LU0417516571.SGD","LU2051468812.USD","LU0384037296.USD","LU0828237940.HKD","LU2293587155.HKD","LU0878004406.USD","LU0054450605.USD","LU2471134796.USD","LU2602419157.SGD","IE00BQXX3C00.GBP","LU2462157665.USD","LU0345776255.USD","LU0878005551.USD","LU2362541273.HKD","LU1719994722.HKD","SG9999006597.SGD","LU0029875118.USD","LU2097828557.USD","LU1196710351.USD","LU1504937902.USD","IE00B0JY6N72.USD","IE00B1XK9C88.USD","LU0231483743.USD","LU1066051811.HKD","LU0868486357.SGD","HK0000320264.USD","IE00B031HW06.USD","LU1951186391.HKD","LU2251237306.USD","SG9999014880.SGD","LU0259732245.USD","LU1861559042.SGD","LU0634319403.HKD","LU1226287792.SGD","LU2488822045.USD","HTCD.SI","BK1575","LU0287142896.SGD","LU1152091168.USD","LU1568876335.HKD","LU0143863784.USD","LU0516422366.SGD","LU0082616367.USD","LU0516422952.EUR","LU2237443895.HKD","LU0192582467.USD","LU0169518387.USD","LU1778281490.HKD","LU1688375341.USD","LU2420271590.USD","SG9999014898.SGD","LU0898667661.SGD","LU1852331112.SGD","LU2226246903.HKD","BK1604","LU1066053197.SGD","LU0052750758.USD","LU0210526637.USD","LU0128522744.USD","LU0211977185.USD","LU0449515922.USD","BK4581","LU0700851271.USD","BK1517","LU0820561909.HKD","LU2152927971.USD","MPNGY","LU0269904917.USD","LU1551013342.USD","LU0198837287.USD","LU2237443382.USD","LU2399975544.HKD","LU1008478684.HKD","HK0000320223.HKD","LU0053666078.USD","LU1242518931.SGD","LU1993786604.SGD","LU0210533765.USD","LU0109391861.USD","LU0320765059.SGD","LU2236285917.USD","LU0348783662.USD","LU0672654166.SGD","LU0501845795.SGD","LU1960683339.HKD","LU2498475776.HKD","SG9999006514.SGD","LU2265009873.SGD","LU2290526834.HKD","IE0034235303.USD","BK1516","BK4574","LU0289960550.SGD","LU2471134952.CNY","LU1868838027.USD","LU0541501648.USD","LU1720050803.USD","LU1810669033.SGD","LU0181495838.USD","LU1226287529.USD","LU0107464264.USD","LU0348723411.USD","SG9999001689.USD","LU0345770993.USD","LU0531970944.HKD","LU1235295612.USD","LU1303224171.USD","LU0165289439.USD","LU0543330566.HKD","LU0320764755.SGD","LU0577902298.EUR","LU2750360641.GBP","LU0348783233.USD","LU1720051017.SGD","LU2097828805.USD","LU0345770308.USD","LU0070217475.USD","BK4527","LU1655091459.SGD","LU1051768304.USD","IE00B031HY20.USD","LU0862451753.SGD","LU2750360997.AUD","LU1323998911.USD","BK1610","LU1785774172.SGD","BK1521","LU2039709279.SGD","LU0918141705.HKD","LU0577902538.SGD","LU1242518857.USD","LU1868837565.USD","LU0261947096.USD","LU0396098781.USD","LU1807302812.USD","LU1044876610.USD","SG9999001903.USD","LU0823426308.USD","IE00B067MR52.USD","LU2471134879.HKD","LU0683595622.HKD","LU2133065610.SGD","LU2326559502.SGD","SG9999001051.SGD","LU0608807433.USD","LU2247934214.USD","BK4598","BK1531","LU0175139822.USD","LU1629966141.USD","LU0417516738.SGD","BK4585","LU1674673691.USD","LU2417539215.USD","LU0823041008.USD","LU0979878070.USD","SG9999015952.SGD","LU0871576103.HKD","LU0594300179.USD","SG9999001069.SGD","LU1282649810.SGD","LU0106959298.USD","BK1589","LU0449509016.USD","LU2106854487.HKD","LU0061477393.USD","LU0235996351.USD","LU0210527791.USD","LU0163747925.USD","IE0003851619.USD","LU1914381329.SGD","LU1188198961.HKD","LU1675838814.USD","IE00B031J352.USD","LU0516423091.SGD","LU0856984785.SGD","LU1804176565.USD","SG9999000327.SGD","LU0943347566.SGD","LU1718418525.SGD","LU1880383440.USD","LU0823413587.USD","LU1366334651.USD","LU0080751232.USD","LU0056508442.USD","LU0463099449.HKD","LU0328353924.USD","LU2087589342.USD","LU0828238088.HKD","BK4511","LU1196710195.USD","LU2756315664.SGD","LU0326948709.USD","LU0348827113.USD","LU0359202008.SGD","LU0251144936.SGD","LU0865486749.SGD","LU0345769631.USD","SG9999001093.SGD","LU0348735423.USD","LU1917777945.USD","LU1048596156.SGD","LU2008162690.USD","LU0320764599.SGD","LU0314109678.HKD","LU1831875114.USD","LU2148510915.USD","LU0708995153.HKD","LU1048484197.HKD","BK4548","LU0348788117.USD","SGXZ51526630.SGD","LU0117841782.USD","SG9999000459.SGD","SG9999015978.USD","LU1734074674.USD","LU2108987350.USD","HMTD.SI","LU2362540622.SGD","LU0531971595.HKD","LU0097036916.USD","LU1770036033.HKD","IE00B19Z9505.USD","LU0128522157.USD","00100","IE0008368411.USD","LU0828237510.HKD","IE00B19Z8W00.USD","LU0234572021.USD","LU0370786039.SGD","LU0607220059.USD","LU0972618739.USD","BK4533","LU0315178854.USD","LU1674673428.USD","BK6092","LU0149534421.HKD","LU0214875030.USD","LU0488056044.USD","LU0509642566.USD"],"gpt_icon":1},{"id":"2601836368","title":"Press Release: LP Building Solutions to Announce Fourth Quarter and Full Year 2025 Earnings on February 17, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601836368","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601836368?lang=en_us&edition=fundamental","pubTime":"2026-01-08 19:01","pubTimestamp":1767870060,"startTime":"0","endTime":"0","summary":"LP Building Solutions  today announced that it will release financial results for the fourth quarter and full year ended December 31, 2025, on Tuesday, Feb. 17, 2026. The company will host a live conference call at 11 a.m. ET the same day to discuss the results.To participate in the conference call, register here to receive the toll-free dial-in number and a unique access code. A live webcast of the call will also be available through LP's Investor Relations website. Following the event, a replay of the webcast and the accompanying presentation will be archived on the site.As a leader in high-performance building solutions, Louisiana-Pacific Corporation  manufactures engineered wood products that meet the demands of builders, remodelers and homeowners worldwide. LP's extensive portfolio of innovative and dependable products includes Siding Solutions , LP Structural Solutions  and LP Oriented Strand Board. In addition to product solutions, LP provides industry-leading customer service a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4022","TM","BK4099","03160","BK4604","R","BK4559","LPX","BK4555","BK4186","BK4588","BK4585"],"gpt_icon":0},{"id":"2601381762","title":"Press Release: SIR Royalty Income Fund Announces January 2026 Distribution and Increase to Distribution Amount","url":"https://stock-news.laohu8.com/highlight/detail?id=2601381762","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601381762?lang=en_us&edition=fundamental","pubTime":"2026-01-08 06:00","pubTimestamp":1767823200,"startTime":"0","endTime":"0","summary":"BURLINGTON, ON, Jan. 7, 2026 /CNW/ - SIR Royalty Income Fund   today declared a cash distribution of $0.105 per unit for the period December 1, 2025 to December 31, 2025. The distribution amount of $0.105 per unit represents an increase of 5% compared to the prior monthly distribution amount of $0.10 per unit. The distribution will be payable on January 30, 2026 to unitholders of record as at the close of business on January 16, 2026.The Trustees of the Fund believe the increase is appropriate given the performance of the Royalty Pooled Restaurants.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","BK4585","BK4588","BK4022","R","BK4099","SIR","BK4555","03160","TM","BK4232"],"gpt_icon":0},{"id":"2601384616","title":"Trump Tariff Ruling Could Come Friday From Supreme Court: What Investors Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2601384616","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601384616?lang=en_us&edition=fundamental","pubTime":"2026-01-08 05:59","pubTimestamp":1767823140,"startTime":"0","endTime":"0","summary":"The Supreme Court could rule on tariffs as early as Friday. Here's what the ruling could mean for investors and what prediction markets show.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/07/Tariffs-Word-On-U-S--flag.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/07/Tariffs-Word-On-U-S--flag.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/politics/26/01/49771323/trump-tariff-ruling-could-come-friday-from-supreme-court-what-investors-should-know","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/politics/26/01/49771323/trump-tariff-ruling-could-come-friday-from-supreme-court-what-investors-should-know","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0289960550.SGD","LU0823411888.USD","LU2552382058.USD","BK4211","LU0943347566.SGD","LU0265550946.USD","LU2491050071.SGD","LU1201861249.SGD","LU1720051108.HKD","GB00BDT5M118.USD","SG9999002232.USD","BK4604","BK4206","BK4588","LU2211817866.USD","LU1894683348.USD","BK4512","LU1720051017.SGD","LU0345780950.USD","LU0345781412.USD","LU1548497426.USD","LU2168564495.EUR","LU1551013342.USD","LU1267930573.SGD","LU0648001328.SGD","IE00B5TLWC47.USD","LU0128525929.USD","LU2168564149.EUR","LU0234572021.USD","BK4559","LU1861219969.SGD","MMM","LU0820561818.USD","LU1571399168.USD","LU2168564222.USD","LU0256863811.USD","LU0238689110.USD","LU1496350502.SGD","LU0820561909.HKD","BK4558","BK4585","LU2098885051.SGD","LU1718418525.SGD","IE0008368304.USD","LU0511384066.AUD","BK4504","LU0823434740.USD","LU0889566641.SGD","LU2097829019.USD","IE0004445239.USD","LU0234570918.USD","LU0417517546.SGD","IE00BD6J9T35.USD","LU0029864427.USD","LU2168564065.EUR","SG9999004303.SGD","LU0786609619.USD","LU1917777945.USD","BK4155","LU0289961442.SGD","LU2357305700.SGD","LU2360106947.USD","IE000M9KFDE8.USD","LU0477156953.USD","IE00BZ1G4Q59.USD","LU0689472784.USD","LU1551013425.SGD","LU2210149790.SGD","BK4550","LU0289739343.SGD","LU2360032135.SGD","LU1093756325.SGD","LU1116320737.USD","LU2125154935.USD","LU1066053197.SGD","LU1974910355.USD","LU0683600562.USD","LU0079474960.USD","LU0175139822.USD","LU0708994859.HKD","LU1116320901.HKD","SG9999011175.SGD","BK4099","STZ","LU1989763427.SGD","LU1988902786.USD","LU2552382215.SGD","SG9999003800.SGD","LU1066051225.USD","IE00BKVL7J92.USD","BK4566","LU0471298777.SGD","LU1267930813.SGD","LU2106854487.HKD","LU2491049909.HKD","LU2210150020.SGD","LU1303367103.USD","BK4596","LU2023250504.SGD","LU1323610961.USD","LU1064131342.USD","LU1069344957.HKD","BK4555","LU2237438978.USD","BK4561","LU0942090050.USD","LU0323240290.USD","LU2095319765.USD","LU0792757196.USD","LU0868494617.USD","NKE","LU1093756168.USD","LU0471298694.HKD","BK4152","LU0385154629.USD","LU0823434583.USD","LU0310800379.SGD","LU2491050154.USD","LU0630314457.HKD","COST","BK4533","LU0868494708.USD","03160","LU2125154778.USD","BK4169","LU1066051811.HKD","LU1894683264.USD","LU2023250843.SGD","LU1496350171.SGD","DE","LU0130517989.USD","ISBC","TM","BK4146","LU0980610538.SGD","LU0312595415.SGD","LU1066051498.USD","SGXZ23171101.USD","LU0130102774.USD","LU1035775433.USD","IE00BFXG0V08.USD","IE00BZ199S13.USD","LU1989763690.USD","SG9999002521.SGD","SG9999002224.SGD","LU2381873111.SGD","BK4534","LU0265550359.USD","LU2552382132.HKD","LU0787776722.HKD","BK4581","LU2264538146.SGD","LU1861214812.USD","IE00BYQQ9H92.USD","LU2168563687.JPY"],"gpt_icon":1},{"id":"2601893933","title":"Press Release: LifeVantage Appoints Seasoned Technology Executive Mike Edwards as Chief Technology Officer to Drive Digital Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2601893933","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601893933?lang=en_us&edition=fundamental","pubTime":"2026-01-08 05:05","pubTimestamp":1767819900,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Jan. 07, 2026  -- LifeVantage Corporation , a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the addition of Mike Edwards as Chief Technology Officer. Edwards brings more than 25 years of experience as an accomplished senior executive specializing in technology leadership and enterprise transformation.\"Mike is a strategic leader with a strong track record of translating technological innovation into measurable business impact and we are delighted to have him join the LifeVantage team,\" said Steve Fife, President and CEO of LifeVantage. \"His expertise in eCommerce, AI, CRM systems, and mobile technology will be instrumental in accelerating our digital transformation and delivering next-generation technology solutions for our independent Consultants and customers as we continue advancing our growth strategy. Mike's proven ability to scale technology infrastructure will be critical as w","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","BK4183","BK4232","BK4604","BK4588","TM","03160","BK4022","LFVN","BK4099","R","BK4585"],"gpt_icon":0},{"id":"2601386072","title":"Press Release: Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2601386072","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601386072?lang=en_us&edition=fundamental","pubTime":"2026-01-08 05:01","pubTimestamp":1767819660,"startTime":"0","endTime":"0","summary":"BOSTON, Jan. 07, 2026  -- Monte Rosa Therapeutics, Inc.  , a clinical-stage biotechnology company developing novel molecular glue degrader -based medicines, today announced that it has commenced an underwritten public offering of $200.0 million of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of common stock. All of the shares of common stock and pre-funded warrants to purchase shares of common stock in the proposed offering are to be sold by Monte Rosa. Monte Rosa also intends to grant the underwriters a 30-day option to purchase up to an additional $30.0 million of shares of its common stock. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USA","TM","GLUE","BK4539","BK4604","BK4139","BK4099","BK4585","BK4555","03160","BK4588"],"gpt_icon":0},{"id":"2601095548","title":"Press Release: Cadence Announces Fourth Quarter and Fiscal Year 2025 Financial Results Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2601095548","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601095548?lang=en_us&edition=fundamental","pubTime":"2026-01-07 22:11","pubTimestamp":1767795060,"startTime":"0","endTime":"0","summary":"Cadence  will hold its fourth quarter and fiscal year 2025 financial results webcast on Tuesday, February 17, 2026.Participating in the webcast will be Dr. Anirudh Devgan, president and chief executive officer, and John Wall, senior vice president and chief financial officer.Cadence is a market leader in AI and digital twins, pioneering the application of computational software to accelerate innovation in the engineering design of silicon to systems. Our design solutions, based on Cadence's Intelligent System Design strategy, are essential for the world's leading semiconductor and systems companies to build their next-generation products from chips to full electromechanical systems that serve a wide range of markets, including hyperscale computing, mobile communications, automotive, aerospace, industrial, life sciences and robotics. In 2024, Cadence was recognized by the Wall Street Journal as one of the world's top 100 best-managed companies. Cadence solutions offer limitless opportun","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0323239441.USD","LU0124384867.USD","LU2125909247.SGD","LU2720916845.USD","LU1721428347.USD","LU2433249047.HKD","LU0094547139.USD","LU0107464264.USD","BK4023","LU1323610961.USD","LU1861214812.USD","BK4567","IE00BD6J9T35.USD","LU0056508442.USD","SG9999000418.SGD","LU0728928796.USD","IE00BN0W2W23.USD","BK4604","LU1852331112.SGD","LU0354030438.USD","LU1861219969.SGD","BK4232","LU2764263039.SGD","LU1951200564.SGD","LU0353189680.USD","CDNS","R","LU2125909593.SGD","LU2360107325.USD","LU0170899867.USD","LU0724618433.USD","03160","LU0302445910.USD","LU2360106780.USD","LU2063271972.USD","LU2298322129.HKD","LU2087625088.SGD","TM","LU2764263203.CNY","LU2506952337.HKD","LU1923623000.USD","LU2506952410.USD","LU2275660780.HKD","LU1923622614.USD","IE00BN0W2V16.EUR","IE0009356076.USD","BK4585","LU1978683503.SGD","IE00B5949003.HKD","LU2477742899.HKD"],"gpt_icon":0},{"id":"2601806997","title":"Press Release: Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2601806997","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601806997?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:55","pubTimestamp":1767794100,"startTime":"0","endTime":"0","summary":"Payment Closes Out Option Agreement Obligations; Oramed Retains $39 Million Outstanding debt, Convertible Debt, Warrants, and an Ongoing Royalty Interest. NEW YORK, Jan. 7, 2026 /PRNewswire/ -- Oramed Pharmaceuticals Inc.   today announced it has received an $18 million payment from Scilex Holdings Inc., representing full satisfaction of obligations under the Option Agreement. This payment brings Oramed's current returns to $118 million on its original $99.5 million Scilex investment, with additional returns expected from the remaining convertible notes, warrants, and royalties.Oramed retains a $27 million note and a $12 million convertible note with Scilex, convertible at Oramed's option into Scilex equity at $36 per share. If not converted, the note will be repaid by Scilex in quarterly installments through October 2026. Oramed also maintains its warrant position as well as a nine-year royalty interest in Scilex products.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ORMP","BK4555","TM","03160","BK4585","BK4588","BK4604","BK4099"],"gpt_icon":0},{"id":"2601806327","title":"Press Release: Wipro Limited to Announce Results for the Third Quarter Ended December 31, 2025, on January 16, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601806327","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601806327?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:44","pubTimestamp":1767793440,"startTime":"0","endTime":"0","summary":"EAST BRUNSWICK, N.J. & BENGALURU, India----January 07, 2026--. At 7:00 PM IST* , following the results announcement, the senior management will discuss the company's performance for the quarter and answer questions sent by 6:30 PM IST*  to: abhishek.jain2@wipro.com.Dial-in details for the conference call are as below. Click here for the diamond pass link Diamond Pass is a Premium Service. that enables you to connect to your conference call without having to wait for. an operator. If you have a Diamond Pass click the above link to associate. your pin and receive the access details for this conference, if you do not. have a Diamond Pass please register through the link and you will receive. Primary Access Toll Number                   +91 22 6280 1120. Please dial any of the above numbers five to ten minutes ahead of schedule. The operator will provide instructions on asking questions before and during the call.The replay of the call will be available two hours after the end of the call ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","BK4588","WIT","BK4134","TM","03160","BK4523","BK4585","BK4099","BK4555"],"gpt_icon":0},{"id":"2601803159","title":"Press Release: SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2601803159","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601803159?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:00","pubTimestamp":1767790800,"startTime":"0","endTime":"0","summary":"Rita Jain, M.D., joins Board as an Independent Director. MIAMI, Jan. 07, 2026  -- SAB Biotherapeutics, Inc. , a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin  for type 1 diabetes  and other autoimmune diseases, today announced the appointment of David Zaccardelli, Pharm.D. to its Board of Directors as Chair of the Board and the appointment of Rita Jain, M.D., as an independent director, both effective immediately.\"We are excited to welcome Dr. David Zaccardelli and Dr. Rita Jain to our Board of Directors. I, along with the rest of our Board, am confident that David and Rita will make a significant impact on SAB BIO, \" said Samuel J. Reich, CEO, SAB BIO.\"SAB BIO is at the forefront of developing a therapy that may dramatically transform the treatment of Type 1 Diabetes, and, in the future, the lives of people living with other autoimmune diseases. I am excited to join the Board of Directors and partner with the Company as they advance SA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4555","LU1169589451.USD","03160","BK4099","BK4604","R","BK4585","TM","BIO","BK4588","BK4022","LU1169590202.USD","BK4121","BK4232","SABS"],"gpt_icon":0},{"id":"2601870628","title":"Bosch Bets on AI; Beer-Can Plants; Nuclear Fusion","url":"https://stock-news.laohu8.com/highlight/detail?id=2601870628","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601870628?lang=en_us&edition=fundamental","pubTime":"2026-01-07 20:04","pubTimestamp":1767787440,"startTime":"0","endTime":"0","summary":"Bosch Bets on AI, Self-Driving Tech; Bud Brewer Buys Back Can Plants; Fusion Firm's 'Digital Twin' By Mark R. Long | WSJ Logistics Report. Germany's Robert Bosch plans to invest nearly $3 billion on artificial intelligence over the next two years as the auto-parts supplier aims to boost productivity and power new products.At the CES trade show in Las Vegas, Bosch said it would extend its collaboration with Microsoft to use AI to optimize factory production, and presented new AI-based driver-assist systems , the WSJ's Dominic Chopping reports. It also said it would work with Kodiak AI on platforms for driverless trucks , building specialized hardware and software systems to give standard trucks autonomous capabilities. Bosch will supply sensors, steering technology and other hardware.Last year, Bosch said it was looking to harness AI to boost manufacturing productivity and improve supply-chain efficiency to cut costs, as strained market conditions, heightened competition and struggles t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","03160","BK4587","TM","BK4023","BK4585","BK4099","AI","BK4588","BK4604","BK4555","BK4543","BK4528"],"gpt_icon":0},{"id":"2601841826","title":"Market Chatter: Toyota Doubles Down on Hybrids as China Pushes EVs","url":"https://stock-news.laohu8.com/highlight/detail?id=2601841826","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601841826?lang=en_us&edition=fundamental","pubTime":"2026-01-07 08:05","pubTimestamp":1767744320,"startTime":"0","endTime":"0","summary":"Toyota Motor  is pressing ahead with engine and hybrid development despite rapid electrification in China, betting that different markets will require different drivetrains, Nikkei reported Wednesday.The automaker has unveiled the GR GT, a hybrid sports car due around 2027 with a four-liter V8, underscoring Chairman Akio Toyoda's view that engines still have a role alongside environmental technology, according to the report.In the U.S., where EV uptake has slowed, Toyota plans to invest up to $10 billion to expand hybrid production, with hybrids making up about 13% of new-vehicle sales in mid-2025. Some models, including the redesigned RAV4, are now built locally, the report said.In China, where EV competition is fierce and sales have declined for three years, Toyota is focusing on China-specific electric models developed with local partners, such as the bZ3X and upcoming bZ7, even as the multi-track strategy raises costs, according to the report.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4099","BK4585","BK4588","03160","TM","BK4604","BK4555"],"gpt_icon":0},{"id":"2601843198","title":"Press Release: UBS Declares Coupon Payments on 12 ETRACS Exchange Traded Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2601843198","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601843198?lang=en_us&edition=fundamental","pubTime":"2026-01-07 05:30","pubTimestamp":1767735000,"startTime":"0","endTime":"0","summary":"GLDI: linked to the Nasdaq Gold FLOWS 103 Index. SLVO: linked to the Nasdaq Silver FLOWS 106 Index. USOI: linked to the Nasdaq WTI Crude Oil FLOWS 106 Index. UBS Investment Bank today announced coupon payments for 9 ETRACS Exchange Traded Notes traded on the NYSE Arca and expected coupon payments for 3 ETRACS Exchange Traded Notes traded on NASDAQ .NYSE       Prospectus        Valuation                  Record       Payment      Coupon   Payment    Yield. Ticker     Supplement     Date          Ex-Date      Date         Date         Amount   Schedule   . MLPR      Index ETN          12/30/2025     1/13/2026     1/13/2026     2026    $1.6219  Quarterly     11.07%. HDLB      Series B           12/30/2025     1/13/2026     1/13/2026     2026    $0.1182   Monthly      10.97%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","BK4118","LU1863844749.USD","BK4604","LU3187612489.SGD","LU1829250122.USD","LU1863844665.USD","BK4585","BK4588","BK4099","UBS","IE0034235071.USD","03160","BK4555","BK4534","SLVO"],"gpt_icon":0},{"id":"2601909978","title":"Press Release: Outlook Therapeutics Appoints Laura Cantrell as Vice President of Corporate Strategy and Business Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2601909978","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601909978?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:35","pubTimestamp":1767706500,"startTime":"0","endTime":"0","summary":"ISELIN, N.J., Jan. 06, 2026  -- Outlook Therapeutics, Inc. , a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced it has appointed Laura Cantrell as Vice President of Corporate Strategy and Business Development.\"We are very pleased to welcome Laura to Outlook Therapeutics at such a pivotal time in our evolution,\" said Bob Jahr, Chief Executive Officer of Outlook Therapeutics. \"Laura's two decades of global biotechnology experience spanning corporate strategy, business development and portfolio leadership, and her proven ability to identify, evaluate and execute high-value opportunities, will be instrumental as we advance our mission to deliver a differentiated ophthalmic formulation of bevacizumab and pursue opportunities to maximize long-term shareholder value.\". In her role as Vice President of Corporate Strategy and Business Development, Ms. Cantrell will be responsible for leading Outlook Therape","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSTW","BK4099","LU1242518931.SGD","LU1316542783.SGD","LU1951200564.SGD","09399","OTLK","IMST","LMI3.UK","MST","MSTY.UK","LU1951198990.SGD","09799","SMST","LU2250418816.HKD","MSII","3LMI.UK","LU1064131342.USD","LU0979878070.USD","BK4585","BK4595","07399","LU1880398471.USD","MSTY","MSTP","WNTR","MSTX","MSST","MSTZ","APED","MSOO","BK4139","IE0009356076.USD","LENZ","03160","MSDD","MSTK","LU1242518857.USD","SMI3.UK","LU1803068979.SGD","BK4023","07799","MTYY","3SMI.UK","TM","LU0889565833.HKD","BK4543"],"gpt_icon":1},{"id":"2601507897","title":"Press Release: iMDx to Welcome Industry Veteran as Vice President of Medical Affairs to Prepare for Commercial Transplant Assay Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2601507897","media":"Dow Jones","labels":["executive","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601507897?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:01","pubTimestamp":1767704460,"startTime":"0","endTime":"0","summary":"-- Dr. Nick Ioannou brings decades of academia, industry, and clinical. experience in organ transplant, nephrology, cardiology, genetics, and. Dr. Ioannou is a physician-scientist with more than three decades of highly relevant experience spanning clinical practice, diagnostics, regulatory affairs, medical education, and medical affairs. His background includes over fifteen years of field-based collaboration with key opinion leaders across multiple therapeutic areas, particularly in organ transplantation, nephrology, cardiology, pulmonology, genetics, and oncology.Dr. Ioannou received a Bachelor of Science in Microbiology from California State University, Northridge, a Master of Healthcare Administration from Saint Joseph's College of Maine and completed his Medical Doctorate clinical training at Michael Reese Hospital in Chic","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4555","BK4585","IMDX","BK4139","BK4604","BK4099","BK4588","TM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bmo.hk/etfs/en/bmo-etfs/details?fundId=3160#glance","stockEarnings":[{"period":"1week","weight":0.0233},{"period":"1month","weight":0.0318},{"period":"3month","weight":0.1101},{"period":"6month","weight":0.272},{"period":"1year","weight":0.2933},{"period":"ytd","weight":0.0233}],"compareEarnings":[{"period":"1week","weight":0.0202},{"period":"1month","weight":0.0281},{"period":"3month","weight":-0.0054},{"period":"6month","weight":0.0833},{"period":"1year","weight":0.3563},{"period":"ytd","weight":0.0202}],"compareStock":{"symbol":"HSI","name":"HSI"},"yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.022946},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.004916},{"month":3,"riseRate":0.6,"avgChangeRate":0.006364},{"month":4,"riseRate":0.5,"avgChangeRate":0.008324},{"month":5,"riseRate":0.7,"avgChangeRate":0.018942},{"month":6,"riseRate":0.6,"avgChangeRate":0.005141},{"month":7,"riseRate":0.7,"avgChangeRate":0.011742},{"month":8,"riseRate":0.6,"avgChangeRate":0.012306},{"month":9,"riseRate":0.7,"avgChangeRate":0.016617},{"month":10,"riseRate":0.6,"avgChangeRate":0.012292},{"month":11,"riseRate":0.9,"avgChangeRate":0.032469},{"month":12,"riseRate":0.7,"avgChangeRate":0.000596}],"exchange":"SEHK","name":"CAM JAPAN HDG","nameEN":"CAM JAPAN HDG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CAM JAPAN HDG(03160),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CAM JAPAN HDG(03160) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CAM JAPAN HDG,03160,CAM JAPAN HDG股票,CAM JAPAN HDG股票老虎,CAM JAPAN HDG股票老虎国际,CAM JAPAN HDG行情,CAM JAPAN HDG股票行情,CAM JAPAN HDG股价,CAM JAPAN HDG股市,CAM JAPAN HDG股票价格,CAM JAPAN HDG股票交易,CAM JAPAN HDG股票购买,CAM JAPAN HDG股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CAM JAPAN HDG(03160),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CAM JAPAN HDG(03160) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}